# Sudeep Pharma Ltd (SUDEEPPHRM)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹673.35
Day Change: +0.77%
52W High: ₹795
52W Low: ₹524.05
Market Cap: ₹7,333 Cr

## Valuation
P/E: 43.69
P/B: 9.76
EPS: ₹14.86
Book Value: ₹66.5
Dividend Yield: 0%

## Returns
1Y Return: -16.13%

## Profitability
ROE: 0%
ROCE: 30.47%
Debt/Equity: 0.19
Revenue Growth: 49.2%
Profit Growth: 61.9%
EBITDA Margin: 35.48%
Operating Margin: 32.56%

## About
Sudeep Pharma Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Sudeep Pharma Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
- Announcement: Board Meeting Intimation for Approval Of Audited Standalone And Consolidated Financials For The Fourth Quarter And Year Ended 31St March 2026.
- BSE Filing: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

## Access
Current tier: anonymous
More history: Register free to see 1 more year.

## Data Freshness
Quote Updated: 2026-05-24T20:00:15.406Z
Price History Updated: 2026-05-18T22:58:31.173Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:58:31.173Z
Quant Updated: 2026-05-18T22:58:31.173Z
Sentiment Updated: 2026-05-18T22:58:31.173Z
Financials Status: current
Financials Updated: 2026-05-18T12:30:10.383Z
Financials Last Attempt: 2026-05-18T12:30:10.383Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2021)
Revenue: ₹123 Cr
Operating Profit: ₹25 Cr (OPM 21%)
Net Profit: ₹18 Cr
Tax: ₹25 Cr

## Annual P&L History
Mar 2021: Rev ₹123Cr | PAT ₹18Cr | OPM 21%
Mar 2022: Rev ₹215Cr | PAT ₹33Cr | OPM 20%
Mar 2024: Rev ₹343Cr | PAT ₹50Cr | OPM 20%

## Balance Sheet (Mar 2021)
Total Assets: ₹131 Cr
Total Liabilities: ₹131 Cr
Borrowings: ₹20 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%

## Board
- Ketan Jagdishchandra Vyas, Chief Financial Officer
- Rikin Ramanlal Gajjar, Senior General Manager of Accounts & Finance
- Ishwar  Nayi, Senior Manager of Human Resources & Administration
- Dimple Ashwinbhai Mehta, Company Secretary & Compliance Officer
- Serkan  Celebi, Managing Director of Sudeep Pharma B.V

---
Source: rupiya.io/stocks/sudeepphrm
Disclaimer: For research and education only. Not investment advice.